ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment 04 Jun 2023 A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study. Find out more Show/Hide
ICR-discovered drug to enter phase II clinical trial in ovarian cancer thanks to new research collaboration 04 May 2023 An innovative cancer drug discovered by scientists at The Institute of Cancer Research, London, is set to enter a new clinical trial. Find out more Show/Hide
Innovative first in class HSF1 pathway cancer drug shows strong results in new study 05 Apr 2023 A new, oral ‘first in class’ experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows. Find out more Show/Hide
Researchers find immune system link with rare ovarian cancer that could guide future treatment 14 Oct 2021
ESMO 2020: Step forward in treatment for patients with newly diagnosed advanced ovarian cancer 18 Sep 2020
MRI data can predict patient response to treatment and survival in advanced ovarian cancer 30 Jan 2020
ICR calls for wider gene testing in ovarian cancer after approval of olaparib earlier in treatment for women with BRCA mutations 26 Jul 2019